IperionX (NASDAQ:IPX) Reaches New 12-Month Low - Here's Why

Key Points

• IperionX shares fell to a new 52-week low of $15.32, well below their 50-day and 200-day moving averages of $20.99 and $27.44, respectively.
• Analyst sentiment remains broadly positive, with six Buy ratings and one Sell rating producing a “Moderate Buy” consensus and an average price target of $42.00, despite recent target reductions.
• Company insiders bought 663,720 shares worth approximately $2.38 million over the past 90 days, while institutional ownership remains limited at 2.76%.

IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Thursday. The stock traded as low as $15.32 and last traded at $15.3450, with a volume of 58986 shares changing hands. The stock had previously closed at $15.83.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on IPX shares. Roth Capital set a $53.00 target price on shares of IperionX in a research report on Wednesday, August 5th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of IperionX in a report on Friday, July 17th. B. Riley Financial dropped their price target on shares of IperionX from $52.00 to $34.00 and set a "buy" rating on the stock in a research note on Wednesday, September 30th. Finally, Jefferies Financial Group assumed coverage on shares of IperionX in a report on Wednesday, September 2nd. They issued a "buy" rating and a $26.00 price objective on the stock. Six equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $42.00.

IperionX Price Performance

The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.95 and a current ratio of 3.24. The company has a 50 day moving average price of $20.99 and a 200 day moving average price of $27.44.

IperionX (NASDAQ:IPX - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported ($0.50) earnings per share (EPS) for the quarter. As a group, analysts forecast that IperionX Limited Sponsored ADR will post -0.13 earnings per share for the current year.

Insider Activity

In related news, CEO Anastasios Arima purchased 138,720 shares of IperionX stock in a transaction dated Friday, July 10th. The shares were acquired at an average price of $3.58 per share, with a total value of $496,617.60. Following the completion of the transaction, the chief executive officer owned 12,455,502 shares of the company's stock, valued at approximately $44,590,697.16. This trade represents a 1.13% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Todd Hannigan purchased 300,000 shares of the firm's stock in a transaction that occurred on Monday, July 13th. The stock was purchased at an average price of $3.59 per share, with a total value of $1,077,000.00. Following the completion of the purchase, the chairman directly owned 26,633,334 shares of the company's stock, valued at approximately $95,613,669.06. This represents a 1.14% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought 663,720 shares of company stock worth $2,379,118 in the last ninety days.

Institutional Investors Weigh In On IperionX

A number of institutional investors have recently made changes to their positions in the company. Connective Capital Management LLC bought a new position in IperionX during the second quarter worth $160,000. GAMMA Investing LLC increased its stake in IperionX by 40.3% during the second quarter. GAMMA Investing LLC now owns 1,681 shares of the company's stock valued at $50,000 after purchasing an additional 483 shares during the last quarter. DLD Asset Management LP acquired a new stake in shares of IperionX during the first quarter worth $260,000. Private Advisor Group LLC raised its holdings in shares of IperionX by 69.9% during the first quarter. Private Advisor Group LLC now owns 63,111 shares of the company's stock worth $1,643,000 after purchasing an additional 25,964 shares during the period. Finally, Corigliano Investment Advisers LLC bought a new position in shares of IperionX in the 4th quarter worth about $362,000. 2.76% of the stock is currently owned by institutional investors.

About IperionX

IperionX Limited NASDAQ: IPX is a materials technology company focused on developing a U.S.-based, lower-carbon titanium supply chain. The company is working to produce titanium metal, powder and other titanium products for aerospace, defense, automotive, medical and other advanced manufacturing applications.

IperionX is developing its Titan Project in Tennessee, which is designed to supply titanium minerals and support domestic production of titanium products. The project is intended to integrate the processing of titanium mineral resources with downstream manufacturing, reducing reliance on overseas sources of titanium.

The company is also advancing proprietary processing technologies, including its Hydrogen Assisted Metallothermic Reduction process, which is designed to produce titanium metal and powder with lower energy requirements than conventional methods.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.